INST MATERIA MEDICA has a total of 24 patent applications. Its first patent ever was published in 1990. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are AXYS PHARMACEUTICALS, REDDY CHEMINOR INC and INFOSINT SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Australia | 3 | |
#3 | Canada | 3 | |
#4 | Mexico | 3 | |
#5 | United States | 3 | |
#6 | Cuba | 2 | |
#7 | Israel | 2 | |
#8 | New Zealand | 2 | |
#9 | China | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Name | Total Patents |
---|---|---|
#1 | Han Rui | 11 |
#2 | Guo Zong-Ru | 6 |
#3 | Yuan Zhang-Liang | 4 |
#4 | Zhang Juntian | 4 |
#5 | Guo Zongru | 4 |
#6 | Xu Shi-Ping | 4 |
#7 | Chu Fengming | 3 |
#8 | Lestage Pierre | 3 |
#9 | Yang Guangzhong | 3 |
#10 | Ren Zhihong | 3 |
Publication | Filing date | Title |
---|---|---|
US6960611B2 | Sulfonyl-containing 2,3-diarylindole compounds, methods for making same, and methods of use thereof | |
US5968940A | Retinoids and methods of use of same | |
CN1187193A | Retinoids and method of use of same | |
WO9640620A1 | Chalcone retinoids and methods of use of same | |
IL122342D0 | Retinoid derivatives and their use | |
US5155111A | DDB as an agent against BEL-7402 human hepatocarcinoma |